Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis

Romanian Journal of Gastroenterology

Volumn 14, Issue 4, 2005, Pages 357-360

  Preda, Carmen Monica ^a   Vermeire, Severine ^b   Rutgeerts, Paul ^b   Joosens, Sophie ^b   Diculescu, Mircea ^a   Marica, Cǎtǎlin ^a   Ciocârlan, Mihai ^a   Mirea, Virginia ^a   Oproiu, Alexandru ^a  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Crohn's disease; Perinuclear anti neutrophil cytoplasmic antibodies; Ulcerative colitis

Indexed keywords

CELL ANTIBODY; CELL MARKER; PERINUCLEAR NEUTROPHIL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROSPECTIVE STUDY; ROMANIA; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

EID: 29744462363     PISSN: 12214167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM. Soluble interleukin-2 receptors, anti-neutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 1993;34: 658-664.
2. Saxon A, Shanahan F, Landers C, Ganz T, Targan SR. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86: 202-210
3. Shanahan F. Neutrophil autoantibodies in inflammatory bowel disease: are they important? Gastroenterology 1994; 107: 586-5893
4. Bansi DS, Fleming KA, Chapman RW. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre and IgG subclass. Gut 1996; 38: 384-389
5. Kull K, Salupere R, Uibo R, Ots M, Salupere V. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Hepatogastroenterology 1998; 45: 2132-2137.
6. Sachar DB, Andrews HA, Farmer RG, et al. Proposed classification of patient subgroups in Crohn's disease. Gastroenterol Int 1992:5.
7. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15.
8. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing colangitis. Gut 1992; 33: 657-662.
9. Duclos B. Maladie de Crohn, rectocolite hemorragique: des anticorps et des hommes. Gastroenterol Clin Biol 1995; 19: 865-866.
10. Quinton J-F, Sendid B, Reumaux D, et al. Anti- Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-791.
11. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998; 115: 822-829.
12. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr 1999; 134: 447-452.
13. Shanahan F, Duerr RH, Rotter JI, et al. Neutrophil antibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology 1992; 103: 456-461
14. Duerr RH, Targan SR, Landers CJ, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100: 1590-1596
15. Yang P, Jarnerot G, Danielsson D, Tysk C, Lindberg E. p-ANCA in monozygotic twins with inflammatory bowel disease. Gut 1995; 36: 887-890
16. Colombel JF, Reumaux D, Duthilleul P, et al. Antineutrophil cytoplasmic antibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992; 16: 656-660.
17. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001;49:671-677.